19.56

0.41% -0.08

After Hours: 19.56

Ceribell Inc (CBLL)

Overview News Price History Discussions Forecast

Ceribell Inc stock is traded at $19.56, with a volume of 197.20K. It is down -0.41% in the last 24 hours and up +6.42% over the past month. CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.

Previous Close:

$19.64

Open:

$19.64

24h Volume:

197.20K

Relative Volume:

0.61

Market Cap:

$742.16M

Revenue:

$95.07M

Net Income/Loss:

$-60.37M

P/E Ratio:

-12.01

EPS:

-1.6291

Net Cash Flow:

$-50.92M

1W Performance:

+0.05%

1M Performance:

+6.42%

6M Performance:

-16.16%

1Y Performance:

+16.71%

1-Day Range:

$19.43

$19.80

1-Week Range:

$19.04

$20.29

52-Week Range:

$10.85

$24.33

Ceribell Inc Stock (CBLL) Company Profile

Name

Ceribell Inc

Sector

Healthcare (1096)

Industry

Medical Devices (140)

Phone

(800) 436-0826

Address

360 N. PASTORIA AVENUE, SUNNYVALE

Employee

300

Twitter

Next Earnings Date

2026-08-04

Latest SEC Filings

CBLL's Discussions on Twitter

Compare CBLL vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CBLL Ceribell Inc	19.56	742.16M	95.07M	-60.37M	-50.92M	-1.6291
ABT Abbott Laboratories	93.93	163.61B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	329.78	126.42B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	83.87	107.36B	36.36B	4.84B	5.43B	3.7212
BSX Boston Scientific Corp	44.77	66.54B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	92.21	53.09B	6.30B	1.07B	1.09B	1.8406

Ceribell Inc Stock (CBLL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-21-25	Initiated	Raymond James	Strong Buy
Jun-24-25	Initiated	BTIG Research	Buy
Apr-04-25	Initiated	Ladenburg Thalmann	Buy
Nov-05-24	Initiated	BofA Securities	Buy
Nov-05-24	Initiated	Canaccord Genuity	Buy
Nov-05-24	Initiated	JP Morgan	Overweight
Nov-05-24	Initiated	TD Cowen	Buy
Nov-05-24	Initiated	William Blair	Outperform

View All

Ceribell Inc Stock (CBLL) Latest News

Jul 09, 2026

Ceribell CEO Chao sells $776,100 of company stock - Investing.com

Jul 09, 2026

Form 4 CeriBell Inc For: 9 July By Investing.com - Investing.com Canada

Jul 09, 2026

Ceribell CEO Chao sells $776,100 of company stock By Investing.com - Investing.com Canada

Jul 09, 2026

Jul 07, 2026

Ceribell director William Burke sells $43,786 in company stock. By Investing.com - Investing.com Nigeria

Jul 02, 2026

Ceribell director William Burke sells $43,786 in company stock. - Investing.com

Jul 02, 2026

Form 4 CeriBell Inc For: 2 July By Investing.com - Investing.com Canada

Jul 02, 2026

Jun 30, 2026

Major Insider Cashes Out Big in Ceribell Stock Shake-Up - TipRanks

Jun 30, 2026

Ceribell(CBLL.US) Insider Sells US$4.07 Million in Common Stock - Moomoo

Jun 30, 2026

Form 144 Ceribell For: 30 June By Investing.com - Investing.com Nigeria

Jun 30, 2026

Jun 28, 2026

CeriBell (CBLL) Explored as Potential Candidate Among Brain-Computer Interface StocksDividend Cut Risk - dars.gov.et

Jun 28, 2026

Jun 27, 2026

Is CeriBell, Inc. (CBLL) Among the Best Brain-Computer Interface Stocks to Buy? - Yahoo Finance

Jun 27, 2026

CBLL Q1 2026 Earnings: Wider-than-Expected Losses Amid Pre-Revenue StageRevenue Estimate Trend - dars.gov.et

Jun 27, 2026